These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

434 related items for PubMed ID: 33032741

  • 1. Targeting Cyclic Guanosine Monophosphate to Treat Heart Failure: JACC Review Topic of the Week.
    Emdin M, Aimo A, Castiglione V, Vergaro G, Georgiopoulos G, Saccaro LF, Lombardi CM, Passino C, Cerbai E, Metra M, Senni M.
    J Am Coll Cardiol; 2020 Oct 13; 76(15):1795-1807. PubMed ID: 33032741
    [Abstract] [Full Text] [Related]

  • 2. A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of the Efficacy and Safety of the Oral Soluble Guanylate Cyclase Stimulator: The VICTORIA Trial.
    Armstrong PW, Roessig L, Patel MJ, Anstrom KJ, Butler J, Voors AA, Lam CSP, Ponikowski P, Temple T, Pieske B, Ezekowitz J, Hernandez AF, Koglin J, O'Connor CM.
    JACC Heart Fail; 2018 Feb 13; 6(2):96-104. PubMed ID: 29032136
    [Abstract] [Full Text] [Related]

  • 3. The place of vericiguat in the landscape of treatment for heart failure with reduced ejection fraction.
    Aimo A, Castiglione V, Vergaro G, Panichella G, Senni M, Lombardi CM, Emdin M.
    Heart Fail Rev; 2022 Jul 13; 27(4):1165-1171. PubMed ID: 34291399
    [Abstract] [Full Text] [Related]

  • 4. Vericiguat for the treatment of heart failure: mechanism of action and pharmacological properties compared with other emerging therapeutic options.
    Hulot JS, Trochu JN, Donal E, Galinier M, Logeart D, De Groote P, Juillière Y.
    Expert Opin Pharmacother; 2021 Oct 13; 22(14):1847-1855. PubMed ID: 34074190
    [Abstract] [Full Text] [Related]

  • 5. Novel sGC Stimulators and sGC Activators for the Treatment of Heart Failure.
    Breitenstein S, Roessig L, Sandner P, Lewis KS.
    Handb Exp Pharmacol; 2017 Oct 13; 243():225-247. PubMed ID: 27900610
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Vericiguat in heart failure with reduced ejection fraction: hope or solid reality?
    Correale M, Pelaggi G, Catanoso MC, Miccichè S, Teresi L, Bonanno S, Bellocchi P, Poleggi C, Capasso R, Barile M, Visco V, Carluccio E, Nodari S, Ciccarelli M, Dattilo G.
    Heart Fail Rev; 2024 Sep 13; 29(5):1135-1143. PubMed ID: 39044114
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Rationale and design of the SOluble guanylate Cyclase stimulatoR in heArT failurE Studies (SOCRATES).
    Pieske B, Butler J, Filippatos G, Lam C, Maggioni AP, Ponikowski P, Shah S, Solomon S, Kraigher-Krainer E, Samano ET, Scalise AV, Müller K, Roessig L, Gheorghiade M, SOCRATES Investigators and Coordinators.
    Eur J Heart Fail; 2014 Sep 13; 16(9):1026-38. PubMed ID: 25056511
    [Abstract] [Full Text] [Related]

  • 11. Vericiguat for Heart Failure with Reduced Ejection Fraction.
    Lombardi CM, Cimino G, Pagnesi M, Dell'Aquila A, Tomasoni D, Ravera A, Inciardi R, Carubelli V, Vizzardi E, Nodari S, Emdin M, Aimo A.
    Curr Cardiol Rep; 2021 Aug 19; 23(10):144. PubMed ID: 34410527
    [Abstract] [Full Text] [Related]

  • 12. Vericiguat: A New Hope for Heart Failure Patients.
    Chiles R, Al-Horani RA.
    Cardiovasc Ther; 2022 Aug 19; 2022():1554875. PubMed ID: 36618548
    [Abstract] [Full Text] [Related]

  • 13. Soluble guanylate cyclase stimulators in patients with heart failure with reduced ejection fraction across the risk spectrum.
    Butler J, Usman MS, Anstrom KJ, Blaustein RO, Bonaca MP, Ezekowitz JA, Freitas C, Lam CSP, Lewis EF, Lindenfeld J, McMullan CJ, Mentz RJ, O'Connor C, Rosano GMC, Saldarriaga CI, Senni M, Udelson J, Voors AA, Zannad F.
    Eur J Heart Fail; 2022 Nov 19; 24(11):2029-2036. PubMed ID: 36250238
    [Abstract] [Full Text] [Related]

  • 14. Rationale and Design of the VITALITY-HFpEF Trial.
    Butler J, Lam CSP, Anstrom KJ, Ezekowitz J, Hernandez AF, O'Connor CM, Pieske B, Ponikowski P, Shah SJ, Solomon SD, Voors AA, Wu Y, Carvalho F, Bamber L, Blaustein RO, Roessig L, Armstrong PW.
    Circ Heart Fail; 2019 May 19; 12(5):e005998. PubMed ID: 31096775
    [Abstract] [Full Text] [Related]

  • 15. A Systematic Review of the Effect of Vericiguat on Patients with Heart Failure.
    Sahana U, Wehland M, Simonsen U, Schulz H, Grimm D.
    Int J Mol Sci; 2023 Jul 23; 24(14):. PubMed ID: 37511587
    [Abstract] [Full Text] [Related]

  • 16. Vericiguat in patients with worsening chronic heart failure and preserved ejection fraction: results of the SOluble guanylate Cyclase stimulatoR in heArT failurE patientS with PRESERVED EF (SOCRATES-PRESERVED) study.
    Pieske B, Maggioni AP, Lam CSP, Pieske-Kraigher E, Filippatos G, Butler J, Ponikowski P, Shah SJ, Solomon SD, Scalise AV, Mueller K, Roessig L, Gheorghiade M.
    Eur Heart J; 2017 Apr 14; 38(15):1119-1127. PubMed ID: 28369340
    [Abstract] [Full Text] [Related]

  • 17. Therapeutic augmentation of NO-sGC-cGMP signalling: lessons learned from pulmonary arterial hypertension and heart failure.
    Triposkiadis F, Xanthopoulos A, Skoularigis J, Starling RC.
    Heart Fail Rev; 2022 Nov 14; 27(6):1991-2003. PubMed ID: 35437713
    [Abstract] [Full Text] [Related]

  • 18. Vericiguat for the treatment of heart failure with reduced ejection fraction.
    Siddiqi AK, Greene SJ, Fudim M, Mentz RJ, Butler J, Khan MS.
    Expert Rev Cardiovasc Ther; 2023 Apr 14; 21(4):245-257. PubMed ID: 36881733
    [Abstract] [Full Text] [Related]

  • 19. New Therapeutics for Heart Failure: Focusing on cGMP Signaling.
    Mangmool S, Duangrat R, Parichatikanond W, Kurose H.
    Int J Mol Sci; 2023 Aug 16; 24(16):. PubMed ID: 37629047
    [Abstract] [Full Text] [Related]

  • 20. The Role of sGC Stimulators and Activators in Heart Failure With Reduced Ejection Fraction.
    Cordwin DJ, Berei TJ, Pogue KT.
    J Cardiovasc Pharmacol Ther; 2021 Nov 16; 26(6):593-600. PubMed ID: 34487435
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.